Clinical Trial Update: Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP) [Phase 2]

View source ↗

Summary

A Phase 2 safety and tolerability study of QLS-101 in adolescents with Sturge-Weber syndrome-related glaucoma due to elevated episcleral venous pressure has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Sturge-weber Syndrome

Drugs mentioned

• QLS-101

Snippet

Sponsor: Qlaris Bio, Inc. | Conditions: Sturge-Weber Syndrome, Glaucoma | Phase 2 | Status: COMPLETED